231 related articles for article (PubMed ID: 27421992)
21. Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent Mechanism.
Whibley N; Jaycox JR; Reid D; Garg AV; Taylor JA; Clancy CJ; Nguyen MH; Biswas PS; McGeachy MJ; Brown GD; Gaffen SL
J Immunol; 2015 Oct; 195(8):3781-92. PubMed ID: 26336150
[TBL] [Abstract][Full Text] [Related]
22. Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection.
Lanternier F; Barbati E; Meinzer U; Liu L; Pedergnana V; Migaud M; Héritier S; Chomton M; Frémond ML; Gonzales E; Galeotti C; Romana S; Jacquemin E; Angoulvant A; Bidault V; Canioni D; Lachenaud J; Mansouri D; Mahdaviani SA; Adimi P; Mansouri N; Jamshidi M; Bougnoux ME; Abel L; Lortholary O; Blanche S; Casanova JL; Picard C; Puel A
J Infect Dis; 2015 Apr; 211(8):1241-50. PubMed ID: 25057046
[TBL] [Abstract][Full Text] [Related]
23. Inherited CARD9 Deficiency in a Child with Invasive Disease Due to Exophiala dermatitidis and Two Older but Asymptomatic Siblings.
Imanaka Y; Taniguchi M; Doi T; Tsumura M; Nagaoka R; Shimomura M; Asano T; Kagawa R; Mizoguchi Y; Karakawa S; Arihiro K; Imai K; Morio T; Casanova JL; Puel A; Ohara O; Kamei K; Kobayashi M; Okada S
J Clin Immunol; 2021 Jul; 41(5):975-986. PubMed ID: 33558980
[TBL] [Abstract][Full Text] [Related]
24. CARD9 Deficiency Increases Hippocampal Injury Following Acute Neurotropic Picornavirus Infection but Does Not Affect Pathogen Elimination.
Pavasutthipaisit S; Stoff M; Ebbecke T; Ciurkiewicz M; Mayer-Lambertz S; Störk T; Pavelko KD; Lepenies B; Beineke A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209576
[TBL] [Abstract][Full Text] [Related]
25. Loss of CARD9-mediated innate activation attenuates severe influenza pneumonia without compromising host viral immunity.
Uematsu T; Iizasa E; Kobayashi N; Yoshida H; Hara H
Sci Rep; 2015 Dec; 5():17577. PubMed ID: 26627732
[TBL] [Abstract][Full Text] [Related]
26. CARD9 mediates dendritic cell-induced development of Lyn deficiency-associated autoimmune and inflammatory diseases.
Ma J; Abram CL; Hu Y; Lowell CA
Sci Signal; 2019 Oct; 12(602):. PubMed ID: 31594855
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation.
Cao Z; Conway KL; Heath RJ; Rush JS; Leshchiner ES; Ramirez-Ortiz ZG; Nedelsky NB; Huang H; Ng A; Gardet A; Cheng SC; Shamji AF; Rioux JD; Wijmenga C; Netea MG; Means TK; Daly MJ; Xavier RJ
Immunity; 2015 Oct; 43(4):715-26. PubMed ID: 26488816
[TBL] [Abstract][Full Text] [Related]
28. Recalcitrant primary subcutaneous phaeohyphomycosis due to Phialophora verrucosa.
Gao LJ; Yu J; Wang DL; Li RY
Mycopathologia; 2013 Feb; 175(1-2):165-70. PubMed ID: 23264134
[TBL] [Abstract][Full Text] [Related]
29. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens.
Hsu YM; Zhang Y; You Y; Wang D; Li H; Duramad O; Qin XF; Dong C; Lin X
Nat Immunol; 2007 Feb; 8(2):198-205. PubMed ID: 17187069
[TBL] [Abstract][Full Text] [Related]
30. A case of disseminated subcutaneous phaeohyphomycosis caused by Exserohilum rostratum with CARD9 mutation.
Kalantri M; Khopkar U; Shah A; Bargir UA; Hule G; Madkaikar M
Indian J Dermatol Venereol Leprol; 2021; 88(1):59-61. PubMed ID: 34245520
[TBL] [Abstract][Full Text] [Related]
31. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency.
Drewniak A; Gazendam RP; Tool AT; van Houdt M; Jansen MH; van Hamme JL; van Leeuwen EM; Roos D; Scalais E; de Beaufort C; Janssen H; van den Berg TK; Kuijpers TW
Blood; 2013 Mar; 121(13):2385-92. PubMed ID: 23335372
[TBL] [Abstract][Full Text] [Related]
32. Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency.
Alves de Medeiros AK; Lodewick E; Bogaert DJ; Haerynck F; Van Daele S; Lambrecht B; Bosma S; Vanderdonckt L; Lortholary O; Migaud M; Casanova JL; Puel A; Lanternier F; Lambert J; Brochez L; Dullaers M
J Clin Immunol; 2016 Apr; 36(3):204-9. PubMed ID: 26961233
[TBL] [Abstract][Full Text] [Related]
33. Role of CARD9 in Cell- and Organ-Specific Immune Responses in Various Infections.
Lee JS; Kim C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473845
[TBL] [Abstract][Full Text] [Related]
34. Impairment of Th cell response in Card9 knockout mice with cutaneous mucormycosis caused by Rhizopus arrhizus.
Sun L; Wan Z; Li R; Yu J
Exp Dermatol; 2019 Nov; 28(11):1244-1251. PubMed ID: 31407820
[TBL] [Abstract][Full Text] [Related]
35. Challenges towards management of CARD9-deficient patients with phaeohyphomycosis: A case report and case series study.
Zhang L; Zhang Y; Ma Y; Wang Z; Wan Z; Song Y; Wang X; Li R
Mycoses; 2023 Apr; 66(4):317-330. PubMed ID: 36527168
[TBL] [Abstract][Full Text] [Related]
36. Generalized subcutaneous phaeohyphomycosis caused by Phialophora verrucosa: report of a case and review of literature.
Tong Z; Chen SC; Chen L; Dong B; Li R; Hu Z; Jiang P; Li D; Duan Y
Mycopathologia; 2013 Apr; 175(3-4):301-6. PubMed ID: 23392822
[TBL] [Abstract][Full Text] [Related]
37. Mechanistic Insights into the Role of C-Type Lectin Receptor/CARD9 Signaling in Human Antifungal Immunity.
Drummond RA; Lionakis MS
Front Cell Infect Microbiol; 2016; 6():39. PubMed ID: 27092298
[TBL] [Abstract][Full Text] [Related]
38. An ITAM-Syk-CARD9 signalling axis triggers contact hypersensitivity by stimulating IL-1 production in dendritic cells.
Yasukawa S; Miyazaki Y; Yoshii C; Nakaya M; Ozaki N; Toda S; Kuroda E; Ishibashi K; Yasuda T; Natsuaki Y; Mi-ichi F; Iizasa E; Nakahara T; Yamazaki M; Kabashima K; Iwakura Y; Takai T; Saito T; Kurosaki T; Malissen B; Ohno N; Furue M; Yoshida H; Hara H
Nat Commun; 2014 May; 5():3755. PubMed ID: 24806599
[TBL] [Abstract][Full Text] [Related]
39. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies.
Wang X; Wang W; Lin Z; Wang X; Li T; Yu J; Liu W; Tong Z; Xu Y; Zhang J; Guan L; Dai L; Yang Y; Han W; Li R
J Allergy Clin Immunol; 2014 Mar; 133(3):905-8.e3. PubMed ID: 24231284
[No Abstract] [Full Text] [Related]
40. Deletion of hematopoietic Dectin-2 or CARD9 does not protect against atherosclerotic plaque formation in hyperlipidemic mice.
Thiem K; Hoeke G; van den Berg S; Hijmans A; Jacobs CWM; Zhou E; Mol IM; Mouktaroudi M; Bussink J; Kanneganti TD; Lutgens E; Stienstra R; Tack CJ; Netea MG; Rensen PCN; Berbée JFP; van Diepen JA
Sci Rep; 2019 Mar; 9(1):4337. PubMed ID: 30867470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
